Life sciences

#Covid-19 #Healthcare #Life sciences #Lipids

Evonik eyes Canadian opportunities in Covid-19 fight 

Evonik met with a delegation of representatives from Canada at its site in Darmstadt to discuss competencies in lipid nanoparticles at Evonik’s Vancouver laboratories and evaluate future collaboration opportunities.   Evonik has sites in seven locations in Canada including its Vancouver Laboratories in British Columbia for lipid-based parenteral drug delivery which… Read More

#News #Trending News #Trends & Analysis

#Animal models #Animal testing #Life sciences

How an animal model provider can save your resources 

Listen to this article on the DDW Podcast: John Couse, PhD, Vice President, Scientific Services, Taconic Biosciences, explains how focussing on best practices for animal models can reduce a project’s timeline, budget, and total number of animals used.   Research organisations engaged in drug discovery rely on animal models, including genetically… Read More

#Business & Investment #Exclusive Content #Opinion

#Life sciences #Software

Azenta Life Sciences’ introduction into the drug discovery sector 

Brooks Life Sciences Services and Products businesses has been rebranded under a new identity – Azenta Life Sciences. Azenta will bring together Brooks’ existing portfolio of life sciences products and services to deliver integrated sample exploration and management solutions. DDW’s Megan Thomas caught up with Linda De Jesus, Senior Vice President and… Read More

#Editor's Choice #Exclusive Content #News

#Alzheimer's #Drug discovery #Genetics #Life sciences #Neuroscience #Therapeutics

Is new thinking the key to unlocking Alzheimer’s treatment?

Professor Paul Whiting, Chief Scientific Officer of The Alzheimer’s Research UK UCL Drug Discovery Institute (ARUK UCL DDI), and Stephane Martinez, product manager and neuroscience expert in PerkinElmer’s Life Sciences segment, share expert insights on Alzheimer’s Disease research today and where discovery and therapeutic approaches might be headed next. Read More

#Editor's Choice #News #Opinion

#Biology #DNA #Funding #Life sciences

DNA Script raises $165M to accelerate enzymatic DNA printing platform  

DNA Script has raised $165 million in a Series C financing led by Coatue Management and Catalio Capital Management, whose representatives have joined as board observers. The new funds will be used to accelerate expansion and commercialisation of the company’s SYNTAX Platform and broaden the portfolio of products powered by EDS.  DNA Script… Read More

#News

#AI #AI / data analytics / healthtech / informatics #Data #Healthcare #Life sciences #Machine learning

Making life science data work for the digital age

The life sciences data landscape is growing in complexity and scale, with organisations generating increasingly high volumes of data. Yet, these data are still stored and searched using outdated methods. As a result, there are vast amounts of unstructured data stored in various siloed locations. Vladimir Makarov, Consultant at Pistoia… Read More

#Exclusive Content #News #Opinion

#Clinical trials #Data #Drug discovery #Life sciences

Clinical trials, the pandemic and technology 

Listen to this article on the DDW Podcast: Chris Sigley, CEO of Arkivum, says the transformation of clinical trials demands a transformed approach to trial data  The pandemic has created manifold challenges for clinical trials, but it has also proved a transformational force. The life sciences sector has succeeded in making a… Read More

#Exclusive Content #Trends & Analysis

#Collaboration #Digital focus #Life sciences #Public health

Pistoia Alliance responds to the needs of the life science industry 

The Pistoia Alliance has announced plans to respond to the changing needs of the life science industry as digital transformation accelerates.  The Alliance has hired Imran Haq, Anca Ciobanu and Linda Kasim to lead the three new themes of its reorganised project portfolio: Emerging Science and Technology,… Read More

#News

#Automation / robotics #Biobanking #Biorepository #Clinical research #Life sciences #Research

Brooks Automation and Cleveland Clinic biobank collaboration 

Brooks Automation and Cleveland Clinic have opened a 22,000-square-foot biospecimen sample management and repository facility on Cleveland Clinic’s main campus.   The biorepository is managed by Azenta Life Sciences, Brooks’ recently re-branded life sciences division, and includes ultra-cold and cryogenic storage for researchers at Cleveland Clinic and other institutions. The… Read More

#News

#Covid-19 #ELRIG #Life sciences

Reflections from Steve Rees, OBE recipient

Acknowledging a successful career, a significant contribution to drug discovery and the ELRIG community, as well as a recent OBE, Steve Rees, VP Discovery Biology, R&D, AstraZeneca, discusses pivotal moments in his career, the work he coordinated around the Cambridge Covid-19 Test Centre, and his eagerness to re-connect with friends and colleagues… Read More

#Covid-19 #Editor's Choice #Exclusive Content #News

#Biopharmaceuticals #Life sciences #Regulatory

Ex-MHRA scientist leads powerhouse trio’s new biopharma excellence brand 

PharmaLex Group has announced the launch of a new service line, Biopharma Excellence, and the appointment of ex-MHRA scientific lead Dr Christian Schneider as its Chief Medical Officer.   Biopharma Excellence is a fusion of three scientific organisations, PharmaLex, ERA Consulting and Biopharma Excellence, under the PharmaLex brand. The new service line combines 35+ years of… Read More

#News #Regulatory

#Collaboration #Drug development #Drug discovery #Life sciences

Brooks introduces Azenta Life Sciences to advance sample solutions 

Brooks Life Sciences Services and Products businesses will be rebranded under the creation of a new identity – Azenta Life Sciences. Azenta will bring together Brookes’ existing portfolio of life sciences products and services to deliver integrated enterprise-wide sample exploration and management solutions.  “We are excited to announce the creation of Azenta as… Read More

#News

#Biopharma #Biotechnology #Collaboration #Life sciences #Technology

Why quantum computing in drug discovery needs to improve  

The Pistoia Alliance has released new results from a survey of 260 attendees from life science companies across the globe, finding that almost half classify their understanding of quantum computing (QC) technology at the beginner level (48%) only. This is followed by intermediate (29%), advanced (13%), and expert at 9%. Read More

#News #Trends & Analysis

#Biotechnology #Life sciences

Lithuania eyes major window of opportunity in life sciences 

Enterprise Lithuania and the Lithuanian Biotechnology Association has announced that in 2020, the Lithuanian biotechnology sector grew by a record 87% and accounted for 2.5% of the Baltic nation’s GDP. Industry leaders gathering at the upcoming Life Sciences Baltics forum are now calling for more international collaborations, increased investment and… Read More

#Market Reports #News #Trending News

#AI #Biotechnology #Events #Life sciences #Microbiome #Webinar

Free virtual event on microbiome research 

Microbiome experts from Microba Life Sciences will discuss the next phase of discovery from the microbiome to a global audience via a series of webinars on September 15 (PST 10am-12pm | EST 1-3pm | CET 7pm).  Professor Gene Tyson, Associate Professor Lutz Krause and Dr Alena Pribyl will discuss how advancements in metagenomic… Read More

#News

#Bioinformatics #Data #Life sciences

Pluto Biosciences launches collaborative life sciences platform 

Pluto Biosciences has launched a cloud-based, collaborative life sciences platform that leverages technology developed at the Wyss Institute for Biologically Inspired Engineering at Harvard University. The Pluto platform simplifies secure, collaborative data sharing and bioinformatics analysis for academic, biotech, and pharmaceutical organisations.   The Pluto platform was built to… Read More

#News